SCHEMBL25599429

SCHEMBL25599429

COC1CCCN(c2nc3cc([N+](=O)[O-])c(C)cc3n2C)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.38
HPGD P15428 1/20 0.37
MAP4K4 O95819 1/20 0.36
ALDH1A1 P00352 5/20 0.36
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
KCNH2 Q12809 3/20 0.34
LMNA P02545 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
ACACB O00763 1/20 0.33
USP2 O75604 1/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
THRB P10828 1/20 0.32
S100A4 P26447 1/20 0.32
HTT P42858 1/20 0.32
RECQL P46063 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25599242 0.85 ALDH1A1 (0.40) HSD11B1HPGDALDH1A1MEN1KMT2A
SCHEMBL25599182 0.85 LMNA (0.45) HSD11B1HPGDALDH1A1MEN1KMT2A
SCHEMBL30533962 0.82 HSD11B1 (0.35) HSD11B1ALDH1A1KCNH2TRPV1
SCHEMBL30533961 0.82 HSD11B1 (0.35) HSD11B1ALDH1A1KCNH2TRPV1
SCHEMBL25281606 0.82 HSD11B1 (0.35) HSD11B1ALDH1A1KCNH2TRPV1
SCHEMBL25223448 0.82 HSD11B1 (0.35) HSD11B1ALDH1A1KCNH2TRPV1
SCHEMBL30464352 0.75 HSD11B1 (0.36) HSD11B1ALDH1A1MEN1KMT2ALMNA
SCHEMBL25225783 0.75 HSD11B1 (0.36) HSD11B1ALDH1A1MEN1KMT2ALMNA
SCHEMBL25599264 0.75 KCNH2 (0.44) HSD11B1ALDH1A1MEN1KMT2AKCNH2
SCHEMBL25681380 0.74 CTSC (0.40) ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023102184-A1 BICYCLIC AMINE COMPOUNDS AS CDK12 INHIBITORS INCYTE CORPORATION (US) 2023-06-08 WO disclosed